関連する実験動画

Updated: Sep 8, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

乳がんの進化を調節するTβ4/SLC7A11信号経路のメカニズム研究

Zhaoyan Jin¹, Hongshu Li¹, Jiafeng Li¹

¹Department of Central Laboratory, Yanbian University Hospital, Yanji, PR China; Department of Pathology and Cancer Research Center, Yanbian University, Yanji, China.

Cellular signalling

|September 5, 2025

まとめ

ティモシンβ4 (Tβ4) は,フェロプトーシスを阻害するSLC7A11を上調することで,乳がんの成長を促します. このTβ4/SLC7A11経路をターゲットにすることで,乳がんにおける治療抵抗性を克服することができる.

科学分野:

腫瘍学
分子生物学
生物化学

背景:

タイモシンβ4 (Tβ4) は乳がんの進行に関与しているが,その正確な分子メカニズムは完全に理解されていない.
乳がん組織における高Tβ4発現は有害な臨床結果と相関しており,悪性腫瘍における重要な役割を示唆している.

研究の目的:

Thymosin β4 (Tβ4) が乳がんの進行に寄与する分子メカニズムを解明する.
増殖,移動,フェロプトーシスなどの癌細胞の行動を調節するTβ4の役割を調査する.

主な方法:

乳がん組織と細胞系におけるTβ4発現の定量分析
ガン細胞の増殖,移動,EMT,血管新生およびアポトーシスに対するTβ4の影響を評価するインビトロおよびインビボ機能検査.
SLC7A11を含むTβ4の直接標的の特定と検証を含むメカニズム研究.
Tβ4/SLC7A11軸が腫瘍性効果を媒介する役割を確認するための救出実験.

主要な成果:

Tβ4は乳がんにおいて著しく上昇し,予後不良と関連している.
Tβ4は乳がん細胞の増殖,移動,上皮-メゼンキーマ移行 (EMT) および血管新生を促進し,同時にアポトーシスを抑制する.
Tβ4はSLC7A11の発現を直接上調し,グルタチオンの合成を増加させ,脂質過酸化を抑制し,それによってフェロプトーシスを抑制する.
SLC7A11を静止すると,Tβ4の腫瘍誘発効果は in vitro と in vivo で逆転した.

結論:

フェロプトーシスを抑制することで乳がんの悪性発症を促進する新しいチモシンβ4 (Tβ4) / SLC7A11信号軸が特定されました.
このTβ4/SLC7A11経路は,乳がんの治療においてフェロプトーシス抵抗を克服するための潜在的な治療目標です.

キーワード:

乳がんフェロプトーシス SLC7A11 ティモシンベータ4 (Tβ4)

さらに関連する動画

Spheroid Assay to Measure TGF-β-induced Invasion

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

関連する概念動画

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Canonical Wnt Signaling Pathway

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Non-Canonical Wnt Signaling Pathways

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...